Xiang Peng

机构：Leshan Normal University · ORCID：0000-0001-5285-9413

发表论文 10 篇 · 总被引 135 次 · h-index 6

代表论文

• Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study (2023 · Clinical and Experimental Medicine · 被引 41)
• Efficacy and Safety of Vonoprazan-Amoxicillin Dual Regimen With Varying Dose and Duration for Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Study (2024 · Clinical Gastroenterology and Hepatology · 被引 31)
• Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study (2023 · Research Square · 被引 18)
• Computed tomography‐based radiomics nomogram using machine learning for predicting 1‐year surgical risk after diagnosis of Crohn's disease (2023 · Medical Physics · 被引 14)
• MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells (2022 · BMC Cancer · 被引 12)
• HLA-DQA1*05 correlates with increased risk of anti-drug antibody development and reduced response to infliximab in Chinese patients with Crohn’s disease (2023 · Gastroenterology report · 被引 9)